newsfilter
← Latest News
GlobeNewswire·

TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

  • TELA Bio will report fourth quarter & full year 2025 financial results on Tuesday, March 24, 2026.
  • Management will host a conference call & webcast at 4:30 p.m. ET to discuss results & provide a corporate update.
  • Investors must register online at least one day in advance or 15 minutes prior to the call start.
  • A live webcast & replay will be available via the Events & Presentations page on TELA Bio's investor website.
  • TELA Bio is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions that prioritize patient anatomy preservation.
  • The company aims to minimize long-term exposure to permanent synthetic materials by leveraging natural healing responses.
  • The press release includes forward-looking statements subject to risks & uncertainties detailed in SEC filings.
  • Investor inquiries should be directed to Louisa Smith at ir@telabio.com.